Search
Nurix Therapeutics Inc
NRIXAdd to Watchlist
23.910USD
-0.350-1.44%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.47BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Redmile Group, LLC
7.83%
BlackRock Institutional Trust Company, N.A.
7.51%
Deep Track Capital LP
6.80%
General Atlantic LLC
4.74%
Vestal Point Capital, LP
4.54%
Other
68.59%
Shareholders
Shareholders
Proportion
Redmile Group, LLC
7.83%
BlackRock Institutional Trust Company, N.A.
7.51%
Deep Track Capital LP
6.80%
General Atlantic LLC
4.74%
Vestal Point Capital, LP
4.54%
Other
68.59%
Shareholder Types
Shareholders
Proportion
Investment Advisor
37.89%
Hedge Fund
29.74%
Investment Advisor/Hedge Fund
27.87%
Private Equity
8.17%
Research Firm
6.46%
Individual Investor
1.09%
Venture Capital
0.49%
Bank and Trust
0.33%
Family Office
0.30%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
422
121.98M
118.09%
+25.15M
2025Q4
393
87.65M
85.36%
-7.61M
2025Q3
380
87.96M
86.81%
-4.07M
2025Q2
377
86.78M
113.52%
-3.21M
2025Q1
389
86.54M
113.52%
-3.63M
2024Q4
375
82.62M
109.55%
+7.81M
2024Q3
364
70.42M
104.89%
-2.21M
2024Q2
348
68.70M
107.62%
+7.14M
2024Q1
317
52.13M
105.94%
-5.88M
2023Q4
312
49.16M
101.34%
-6.38M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Redmile Group, LLC
8.09M
7.83%
+4.42M
+120.04%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
7.76M
7.51%
+2.01M
+34.85%
Dec 31, 2025
Deep Track Capital LP
7.04M
6.8%
+979.43K
+16.17%
Dec 31, 2025
General Atlantic LLC
4.90M
4.74%
+4.90M
--
Dec 31, 2025
Vestal Point Capital, LP
4.69M
4.54%
+1.22M
+34.96%
Dec 31, 2025
Morgan Stanley & Co. LLC
4.69M
4.53%
+2.64M
+129.14%
Dec 31, 2025
Baker Bros. Advisors LP
4.66M
4.51%
+776.43K
+20.00%
Dec 31, 2025
Fidelity Management & Research Company LLC
4.00M
3.87%
-3.58M
-47.24%
Dec 31, 2025
State Street Investment Management (US)
3.56M
3.44%
+697.11K
+24.35%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ARK Genomic Revolution ETF
1.79%
Tema Oncology ETF
1.5%
Global X HealthTech ETF
1.11%
Virtus LifeSci Biotech Clinical Trials ETF
0.73%
State Street SPDR S&P Biotech ETF
0.45%
iShares Micro-Cap ETF
0.19%
Direxion Daily S&P Biotech Bull 3X Shares
0.18%
ProShares Ultra Nasdaq Biotechnology
0.16%
Invesco Nasdaq Biotechnology ETF
0.1%
iShares Russell 2000 Value ETF
0.09%
View more
ARK Genomic Revolution ETF
Proportion1.79%
Tema Oncology ETF
Proportion1.5%
Global X HealthTech ETF
Proportion1.11%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.73%
State Street SPDR S&P Biotech ETF
Proportion0.45%
iShares Micro-Cap ETF
Proportion0.19%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion0.18%
ProShares Ultra Nasdaq Biotechnology
Proportion0.16%
Invesco Nasdaq Biotechnology ETF
Proportion0.1%
iShares Russell 2000 Value ETF
Proportion0.09%